Table: Immuno Biological Lab -Q1 group results

Immuno-Biological Laboratories

07/08/2026 07:39

    Aug 7 (Reuters)- 
             Immuno Biological Laboratories Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2026        Jun 30, 2025     Mar 31, 2027 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            286 mln             211 mln           1.09     
                 (+35.2 pct)         (-7.9 pct)       (+8.2 pct)  
  Operating        117 mln             54 mln           322 mln   
                (+116.5 pct)         (+5.4 pct)       (+14.5 pct) 
  Recurring        120 mln             57 mln           322 mln   
                (+108.7 pct)         (+1.7 pct)       (+7.1 pct)  
  Net              100 mln             60 mln           347 mln   
                 (+64.5 pct)         (+18.7 pct)      (+5.5 pct)  
  EPS             10.76 yen           6.54 yen         37.26 yen  
  Ann Div                             6.00 yen         7.50 yen   
  -Q2 div                                NIL              NIL     
  -Q4 div                             6.00 yen         7.50 yen   
  
  NOTE - Immuno Biological Laboratories Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T